HealthDay on MSN3h
Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...
Diabetes, high BMI, previous metformin prescriptions are common in teens with prescriptions for GLP-1 RAs
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...
ahajournals.org5d
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...
healthday on MSN1d
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...
Discovery of a gut-to-brain regulation pathway in flies offers insights into human aging
Biologists at Brown University have discovered how a neuropeptide hormone made in the gut of flies can control their lifespan ...
Mounjaro is more effective for weight loss than Ozempic. So how does it work? And why does it cost so much?
A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...
News Medical on MSN1d
Dietitians boost GLP-1 therapy success with personalized care and side effect management
Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven ...
The American Journal of Managed Care12h
Financial Considerations, Policies for Antiobesity Medication Coverage
Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...
EurekAlert!3d
Risk of suicidal ideation or attempts in adolescents with obesity treated with GLP1 receptor agonists
In this study, adolescents with obesity prescribed a glucagon-like peptide 1 receptor agonists (GLP1R) had a lower incidence of suicidal ideation or attempts compared with matched patients not ...